...
首页> 外文期刊>World Journal of Gastroenterology >Effect of Hewei-Decoction on chronic atrophic gastritis and eradication of Helicobacter pylori.
【24h】

Effect of Hewei-Decoction on chronic atrophic gastritis and eradication of Helicobacter pylori.

机译:合胃汤对慢性萎缩性胃炎和幽门螺杆菌根除的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To demonstrate the effect of Hewei-Decoction (Decoction for regulating the stomach) on chronic atrophic gastritis (CAG) and eradication of Helicobacter pylori. METHODS: Ninety patients with CAG entering the investigation were divided into six differentiation syndromes, based on their major symptoms and signs. Hewei-Decoction was taken by all the patients orally for 4 or 8 wk. The efficacy was assessed by both the composite accumulation of reduced scores of major symptoms and the eradication of H pylori. chi(2) test was used to compare the efficacy between H pylori-positive and negative cases, and to disclose the relationship between efficacy and eradication of H pylori. RESULTS: In patients with six different syndrome types, the efficacy of Hewei-Decoction was 91.67% (11/12), 92.86% (13/14), 97.22% (35/36), 87.50% (14/16), 75.00% (6/8), 75.00% (3/4) respectively. The rate of highly efficacious was 58.33% (7/12), 50.00% (7/14), 77.78% (28/36), 62.50% (10/16), 12.50% (1/8) and 25.00% (1/4), respectively. The total efficacy was 91.11% (82/90), and the rate of highly efficacious was 60.00% (54/90). The eradication rate of H pylori was 67.86% (38/56). The therapeutic effect of Hewei-Decoction was better in H pylori positive cases than that in H pylori-negative cases with the total effect of 96.43% vs 82.35% (P<0.05). In 56 H pylori positive cases, the therapeutic effect was better in H pylori eradicated cases than that in H pylori- existent cases with the total effect of 97.37% vs 72.22% (P<0.01). CONCLUSION: Hewei-Decoction is effective in most cases of all the syndrome types. The results indicate that eradication of H pylori is one of the important mechanisms for alleviation of symptoms and signs. Also, the decoction is efficacious in H pylori-negative cases.
机译:目的:证明合胃汤(调胃汤)对慢性萎缩性胃炎(CAG)和根除幽门螺杆菌的作用。方法:将90名接受CAG检查的患者根据其主要症状和体征分为6种分化综合征。所有患者均口服和味汤4周或8周。通过减少主要症状分数的复合积累和根除幽门螺杆菌来评估疗效。 chi(2)测试用于比较幽门螺杆菌阳性和阴性病例的疗效,并揭示疗效与根除幽门螺杆菌之间的关系。结果:在六种不同综合征类型的患者中,合胃汤的疗效分别为91.67%(11/12),92.86%(13/14),97.22%(35/36),87.50%(14/16),75.00 %(6/8),75.00%(3/4)。高效率分别为58.33%(7/12),50.00%(7/14),77.78%(28/36),62.50%(10/16),12.50%(1/8)和25.00%(1 / 4)。总有效率为91.11%(82/90),高效率为60.00%(54/90)。幽门螺杆菌的根除率为67.86%(38/56)。幽门螺杆菌阳性病例和合汤治疗效果优于幽门螺杆菌阴性病例,总有效率96.43%vs 82.35%(P <0.05)。在56例H幽门螺杆菌阳性病例中,根除H幽门螺杆菌的病例的治疗效果要好于H幽门螺杆菌阳性的病例,总疗效为97.37%对72.22%(P <0.01)。结论:合胃汤对所有证型多数病例有效。结果表明,根除幽门螺杆菌是缓解症状和体征的重要机制之一。而且,该汤剂在幽门螺杆菌阴性病例中是有效的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号